AVGO:NASDAQBroadcom Inc. Analysis
Data as of 2026-08-27 - not real-time
$355.59
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $355.59, Broadcom Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have lost 9.8%. RSI sits at 34.4, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at $350.06 up to resistance at $432.73.
The shares look overvalued, trading on 59.6 times earnings above a sector average of 35.1. The average analyst target implies 47.9% above today's level. Revenue is growing at 47.9% on a 38.8% profit margin. The 0.73% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 42.3%, a beta of 2.16 and a maximum drawdown of 29.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The shares look overvalued, trading on 59.6 times earnings above a sector average of 35.1. The average analyst target implies 47.9% above today's level. Revenue is growing at 47.9% on a 38.8% profit margin. The 0.73% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 42.3%, a beta of 2.16 and a maximum drawdown of 29.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Broadcom NASDAQ:AVGO has drawn significant market attention in 2026 for its custom AI chips.Alex Sirois Mon, August 24, 2026 at 1:05 PM UTC 0 genkur / iStock via Getty Images Quick Read - Broadcom AVGO generated...Marvell has surged further than almost any semiconductor stock in 2026, and now it faces a confirmed earnings event in...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading below the 200-day average of 369.22
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 59.6 versus sector average of 35.1
- Trading below the 200-day average of 369.22
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 59.6 versus sector average of 35.1
- Analyst targets imply +47.9% versus the current price
- Profit margin of 38.8% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth47.90%
Profit Margin38.85%
P/E Ratio59.6
ROE37.28%
ROA12.12%
Debt/Equity74.02
P/B Ratio19.3
Op. Cash Flow$33.6B
Free Cash Flow$27.2B
Industry P/E35.1
Technical Analysis
TrendBullish
RSI34.4
Support$350.06
Resistance$432.73
MA 20$392.90
MA 50$386.69
MA 200$369.22
MACDBearish
VolumeIncreasing
Fear & Greed Index94.84
Valuation
Fair Value$191.76
Target Price$525.97
Upside/Downside47.92%
GradeOvervalued
TypeGrowth
Dividend Yield0.73%
Risk Assessment
Beta2.16
Volatility42.33%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.